Emerging research indicates that Covid-19 mRNA vaccines, including Pfizer-BioNTech and Moderna, may offer surprising benefits beyond viral protection, particularly for cancer patients. Initially developed to prevent infection, these vaccines appear to enhance the body’s immune response in a way that helps target and attack certain tumours. Studies suggest that patients undergoing immunotherapy for advanced lung or skin cancer who receive an mRNA vaccine within a specific timeframe may experience improved treatment outcomes and longer survival. Scientists believe the vaccines “prime” the immune system, making it more responsive to cancer therapies such as checkpoint inhibitors. This unexpected synergy highlights the broader potential of mRNA technology, suggesting that vaccines originally

See Full Page